Press-release for stocks publishing date 2021 - 04

Prices are updated after-hours

501JT, Senior Clinical Trial Manager
Published: 2021-04-13 (Crawled : 01:00) - fatetherapeutics.com
FATE | News | $4.195 -7.6% 900K

| -93.95% | O: 0.01% H: 6.6% C: 5.19%
trial

54%

46%

CSSE 4 | $0.3499 129.74% 150M

CZOO | $11.04 121.24% 9.6M

BOF | $2.05 75.21% 78M

AMST | $3.2 60.0% 63M

LICN | $0.8592 53.43% 13M

WIMI | $1.05 44.75% 13M

MULN | News | $3.675 34.62% 11M

RILY | $28.605 31.7% 9.9M

RBBN 4 | $3.305 28.6% 1.9M

RCAT | $1.53 27.5% 2.9M

Save your searches and get alerts when important news are released.